Hemodilution Guided

Hemodilution controlled

Hemodilution is a method of transfusion therapy, which consists of dosed dilution of blood with plasma replacement fluids to maintain normal blood volume and reduce the risk of complications associated with the transfusion of blood components. This method is widely used in medicine to treat various diseases such as anemia, hemolytic disease of the newborn, severe burns and others.

The way hemodilution works is that the patient's blood is diluted with a plasma replacement fluid such as saline or dextran. In this case, the blood volume decreases, but the concentration of red blood cells and other formed elements remains normal. This reduces the risk of complications associated with overloading the body with blood components, such as blood clots, hypercoagulability and deterioration of organ function.

It is important to note that hemodilution is not an independent method of treatment, but only complements other methods of therapy. It can be used in combination with other methods, such as red blood cell transfusion or plasmapheresis, to achieve optimal effect.

In general, hemodilution is an effective method of transfusion therapy and is widely used in medicine. However, like any other treatment method, it has its contraindications and can cause side effects. Therefore, before starting treatment, it is necessary to carefully evaluate the patient and evaluate the risks and benefits of hemodilution.

Controlled hemodilution therapy (UDT) is one of the main methods of treating severe anemia of various origins in patients with acute blood loss or post-hemorrhagic exhaustion. The most important parts of the general mechanism of action of UDT is the replacement of iron deficiency